1. 3'UTR-CDKN2A and CDK4 Germline Variants Are Associated With Susceptibility to Cutaneous Melanoma
- Author
-
David Tovar-Parra, Sebastián Ramiro Gil-Quiñones, Luz D Gutiérrez-Castañeda, and John Alexander Nova
- Subjects
Oncology ,Male ,Cancer Research ,medicine.medical_specialty ,Skin Neoplasms ,Lentigo maligna ,Acral lentiginous melanoma ,General Biochemistry, Genetics and Molecular Biology ,CDKN2A ,Internal medicine ,Genetic variation ,medicine ,Humans ,Genetic Predisposition to Disease ,neoplasms ,3' Untranslated Regions ,Melanoma ,Cyclin-Dependent Kinase Inhibitor p16 ,Germ-Line Mutation ,Pharmacology ,business.industry ,Haplotype ,Cancer ,Cyclin-Dependent Kinase 4 ,medicine.disease ,Cutaneous melanoma ,business ,Research Article - Abstract
Background/aim Genetic variations of the CDKN2A and CDK4 gene have been associated to melanoma development. In the present study we investigated the potential associations of CDKN2A and CDK4 gene variants in a colombian population diagnosed with melanoma. Materials and methods DNA was extracted from whole blood samples from 85 patients diagnosed with cutaneous melanoma and 166 healthy controls. CDKN2A and CDK4 genes were genotyped using a high-resolution melting assay. Results A similar distribution of CDKN2A variants 500C>G and 540C>T was found among cases (12% and 31% respectively) and controls (15% and 31% respectively). The CDKN2A variants were present in 36% of acral lentiginous melanoma and 39.47% of lentigo maligna. The haplotype analysis showed an association with susceptibility in the development of melanoma. Conclusion The presence of haplotype 500G/540C in males is associated with an increased risk of melanoma in a colombian population, especially in subjects with a family history of cancer.
- Published
- 2021